G H Blijham - JoVE Visualize

Showing results (101-110 of 109) with videos related to

Pageof 11

Sort By:

You have reached the last page of results.This site can display upto 109 results.

The Netherlands Journal of Medicine|June 1, 1992

A randomized trial of two doses of granisetron in the treatment of chemotherapy-induced emesis. Dutch results within a multinational studyM W Bots, H J Dijkstra, G H Blijham, et al.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 1, 1996

Efficacy of rhenium-186-etidronate in prostate cancer patients with metastatic bone painJ M Quirijnen, S H Han, B A Zonnenberg, et al.

Journal of Internal Medicine|October 1, 1995

From medical history and biochemical tests to presymptomatic treatment in a large MEN 2A familyC J Lips, R M Landsvater, J W Höppener, et al.

The American Journal of Medicine|December 1, 1996

Familial medullary thyroid carcinoma: not a distinct entity? Genotype-phenotype correlation in a large familyA M Moers, R M Landsvater, C Schaap, et al.

British Journal of Cancer|December 17, 2003

Phase I clinical trial of the bispecific antibody MDX-H210 (anti-FcgammaRI x anti-HER-2/neu) in combination with Filgrastim (G-CSF) for treatment of advanced breast cancerR Repp, H H van Ojik, T Valerius, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1996

Effects of medroxyprogesterone acetate on appetite, weight, and quality of life in advanced-stage non-hormone-sensitive cancer: a placebo-controlled multicenter studyJ P Simons, N K Aaronson, J F Vansteenkiste, et al.

The Journal of Steroid Biochemistry and Molecular Biology|February 19, 2002

Aromatase and COX-2 expression in human breast cancersA M Brodie, Q Lu, B J Long, et al.

European Journal of Cancer (Oxford, England : 1990)|April 22, 1999

Clinical activity and benefit of irinotecan (CPT-11) in patients with colorectal cancer truly resistant to 5-fluorouracil (5-FU)E Van Cutsem, D Cunningham, W W Ten Bokkel Huinink, et al.

Breast Cancer Research and Treatment|May 18, 2011

Epirubicin and paclitaxel with G-CSF support in first line metastatic breast cancer: a randomized phase II study of dose-dense and dose-escalated chemotherapyR I Lalisang, F L G Erdkamp, C J Rodenburg, et al.

Pageof 11

Showing results (101-110 of 109) with videos related to

Sort By:

Pageof 11

You have reached the last page of results.This site can display upto 109 results.

The Netherlands Journal of Medicine|June 1, 1992

A randomized trial of two doses of granisetron in the treatment of chemotherapy-induced emesis. Dutch results within a multinational studyM W Bots, H J Dijkstra, G H Blijham, et al.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 1, 1996

Efficacy of rhenium-186-etidronate in prostate cancer patients with metastatic bone painJ M Quirijnen, S H Han, B A Zonnenberg, et al.

Journal of Internal Medicine|October 1, 1995

From medical history and biochemical tests to presymptomatic treatment in a large MEN 2A familyC J Lips, R M Landsvater, J W Höppener, et al.

The American Journal of Medicine|December 1, 1996

Familial medullary thyroid carcinoma: not a distinct entity? Genotype-phenotype correlation in a large familyA M Moers, R M Landsvater, C Schaap, et al.

British Journal of Cancer|December 17, 2003

Phase I clinical trial of the bispecific antibody MDX-H210 (anti-FcgammaRI x anti-HER-2/neu) in combination with Filgrastim (G-CSF) for treatment of advanced breast cancerR Repp, H H van Ojik, T Valerius, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1996

Effects of medroxyprogesterone acetate on appetite, weight, and quality of life in advanced-stage non-hormone-sensitive cancer: a placebo-controlled multicenter studyJ P Simons, N K Aaronson, J F Vansteenkiste, et al.

The Journal of Steroid Biochemistry and Molecular Biology|February 19, 2002

Aromatase and COX-2 expression in human breast cancersA M Brodie, Q Lu, B J Long, et al.

European Journal of Cancer (Oxford, England : 1990)|April 22, 1999

Clinical activity and benefit of irinotecan (CPT-11) in patients with colorectal cancer truly resistant to 5-fluorouracil (5-FU)E Van Cutsem, D Cunningham, W W Ten Bokkel Huinink, et al.

Breast Cancer Research and Treatment|May 18, 2011

Epirubicin and paclitaxel with G-CSF support in first line metastatic breast cancer: a randomized phase II study of dose-dense and dose-escalated chemotherapyR I Lalisang, F L G Erdkamp, C J Rodenburg, et al.

Pageof 11